Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.

Polish journal of pharmacology - 1 Jan 2000

William Basem M, Abdel-tawab Ahmed M, Hassan Essam A, Mohamed Omar Fathy

Abstract excerpt

OBJECTIVE: The study was designed to answer the question whether a particular (slow/fast) acetylator phenotype is a risk for malignant lymphoma patients. Differences in acetylator phenotypes were previously described in urinary bladder and colorectal carcinoma patients compared to controls. Addressing this issue may help understanding the possible role of xenobiotics' metabolism in the pathogenesis of malignant...

Topics

Acetylation
Acetyltransferases
Adolescent
Adult
Aged
Caffeine
Child
Female
Humans
Inactivation, Metabolic
Lymphoma
Male
Middle Aged
Phenotype
Time Factors

Source

Open in PubMed

Identifiers

PMID: 15520499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics